entrepreneurs
Most Read
Stoke Therapeutics drug, targeting genetic cause of childhood epilepsy, reduces seizure activity
Pharmalittle: FDA plans rapid review of Omicron vaccines and drugs; Califf would keep Woodcock at FDA
In defense of not treating everyone the same
Reforms needed for FDA’s regulation of medical devices
We’ll know more soon about Omicron. Here’s how to interpret the coming flood of data
‘Just stupid stuff’: Logistics and lack of testing stymied finding the Omicron variant in the U.S.
